Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
JCI Insight|May 13, 2025
Early multiple sclerosis activity associated with TBX21+CD21loCXCR3+ B cell expansion resembling EBV-induced phenotypesElliott D SoRelle, Ellora Haukenfrers, Gillian Q Horn, et al.
Multiple Sclerosis and Related Disorders|August 28, 2022
The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndromeErin E Longbrake, Le H Hua, Ellen M Mowry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune diseaseOlaf Stüve, Sawsan Youssef, Anthony J Slavin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 28, 2023
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated diseaseSimone Sacco, Akash Virupakshaiah, Nico Papinutto, et al.
JAMA Neurology|August 8, 2013
Therapeutic decisions in multiple sclerosis: moving beyond efficacyWolfgang Brück, Raff Gold, Brett T Lund, et al.
Molecular Pharmacology|January 5, 2024
Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple SclerosisYadira X Perez-Paramo, Dawn Dufield, Rathna Veeramachaneni, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2016
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2Ulf Schulze-Topphoff, Michel Varrin-Doyer, Kara Pekarek, et al.
Archives of Neurology|August 11, 2010
Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?Clemens Warnke, Til Menge, Hans-Peter Hartung, et al.
Plos One|February 10, 2011
Switching multiple sclerosis patients with breakthrough disease to second-line therapyTamara Castillo-Trivino, Ellen M Mowry, Alberto Gajofatto, et al.
Journal of Neuroinflammation|May 28, 2013
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitisPetra D Cravens, Bernd C Kieseier, Rehana Hussain, et al.
Pageof 18